Lobbying disclosures · Lobbying report
BDX: second_quarter 2026 lobbying report
Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act Is
Follow BDX- Became public
- Jul 20, 2026, 3:16 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 12:17 PM EST
Why this is connected
Legal-name match: BECTON DICKINSON AND COMPANY is BECTON DICKINSON & CO (https://www.sec.gov/Archives/edgar/data/10795/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Expenses: $622,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/1d55521b-34e6-4587-b995-63be13078155/","filing_uuid":"1d55521b-34e6-4587-b995-63be13078155","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1d55521b-34e6-4587-b995-63be13078155/print/","filing_document_content_type":"text/html","income":null,"expenses":"622000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Jessica Johnston","dt_posted":"2026-07-20T15:16:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"555 11th St NW","registrant_address_2":"Suite 305","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":5767,"url":"https://lda.gov/api/v1/registrants/5767/","house_registrant_id":32907,"name":"BECTON, DICKINSON AND COMPANY","description":null,"address_1":"555 11th St NW","address_2":"Suite 305","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JESSICA JOHNSTON","contact_telephone":"+1 202-740-7123","dt_updated":"2026-07-23T14:38:47.418747-04:00"},"client":{"id":107474,"url":"https://lda.gov/api/v1/clients/107474/","client_id":12,"name":"BECTON DICKINSON AND COMPANY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69779,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"LOTSPIKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61993,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"JOHNSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154549,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RAMSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154548,"prefix":null,"prefix_display":null,"first_name":"LEO","nickname":null,"middle_name":null,"last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61993,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"JOHNSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69779,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"LOTSPIKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154548,"prefix":null,"prefix_display":null,"first_name":"LEO","nickname":null,"middle_name":null,"last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154549,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RAMSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to corporate taxation Tax incentives for domestic manufacturing","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69779,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"LOTSPIKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61993,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"JOHNSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154548,"prefix":null,"prefix_display":null,"first_name":"LEO","nickname":null,"middle_name":null,"last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154549,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RAMSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69779,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"LOTSPIKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61993,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"JOHNSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154548,"prefix":null,"prefix_display":null,"first_name":"LEO","nickname":null,"middle_name":null,"last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154549,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RAMSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61993,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"JOHNSTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69779,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"LOTSPIKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154548,"prefix":null,"prefix_display":null,"first_name":"LEO","nickname":null,"middle_name":null,"last_name":"FARBER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":154549,"prefix":null,"prefix_display":null,"first_name":"KEVIN","nickname":null,"middle_name":null,"last_name":"RAMSEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in BDX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Becton, Dickinson and Company BDX
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Bought Becton, Dickinson and Company BDX
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 18, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold Becton, Dickinson and Company BDX
$1K–$15K · Traded May 21, 2026 · disclosed Jun 18, 2026
Committee overlap: Energy and Commerce - Apr 3, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
Sold Becton, Dickinson and Company BDX
$15K–$50K · Traded Mar 17, 2026 · disclosed Apr 3, 2026 · Joint
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold Becton, Dickinson and Company BDX
$1K–$15K · Traded Jun 24, 2025 · disclosed Aug 13, 2025 · Spouse · filed 50 days later
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Bought Becton, Dickinson and Company BDX
$1K–$15K · Traded Jun 17, 2025 · disclosed Aug 13, 2025 · Spouse · filed 57 days later
- Jun 17, 2025$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Bought Becton, Dickinson and Company BDX
$1K–$15K · Traded May 13, 2025 · disclosed Jun 17, 2025
Committee overlap: Energy and Commerce - Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
Bought Becton, Dickinson and Company BDX
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.